Literature DB >> 31576361

Outcome of safety and efficacy of allogeneic mesenchymal stromal cell derived from umbilical cord for the treatment of osteoarthritis in a randomized blinded placebo-controlled trial.

Kiran Shah1,2, Huseyin Sumer1.   

Abstract

Entities:  

Year:  2019        PMID： 31576361      PMCID： PMC6685847          DOI： 10.21037/atm.2019.06.39

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  14 in total

1.  Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.

Authors:  Susanne Kern; Hermann Eichler; Johannes Stoeve; Harald Klüter; Karen Bieback
Journal:  Stem Cells       Date:  2006-01-12       Impact factor: 6.277

2.  Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.

Authors:  M Dominici; K Le Blanc; I Mueller; I Slaper-Cortenbach; Fc Marini; Ds Krause; Rj Deans; A Keating; Dj Prockop; Em Horwitz
Journal:  Cytotherapy       Date:  2006       Impact factor: 5.414

Review 3.  Allogeneic mesenchymal stem cells: agents of immune modulation.

Authors:  Karen English; Bernard P Mahon
Journal:  J Cell Biochem       Date:  2011-08       Impact factor: 4.429

Review 4.  Stem Cell Therapies in Clinical Trials: Progress and Challenges.

Authors:  Alan Trounson; Courtney McDonald
Journal:  Cell Stem Cell       Date:  2015-07-02       Impact factor: 24.633

Review 5.  Therapeutic potentials of mesenchymal stem cells derived from human umbilical cord.

Authors:  Cun-Gang Fan; Qing-jun Zhang; Jing-ru Zhou
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

6.  The MSC: an injury drugstore.

Authors:  Arnold I Caplan; Diego Correa
Journal:  Cell Stem Cell       Date:  2011-07-08       Impact factor: 24.633

7.  Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial.

Authors:  Julien Freitag; Dan Bates; James Wickham; Kiran Shah; Leesa Huguenin; Abi Tenen; Kade Paterson; Richard Boyd
Journal:  Regen Med       Date:  2019-02-14       Impact factor: 3.806

8.  OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited.

Authors:  T Pham; D van der Heijde; R D Altman; J J Anderson; N Bellamy; M Hochberg; L Simon; V Strand; T Woodworth; M Dougados
Journal:  Osteoarthritis Cartilage       Date:  2004-05       Impact factor: 6.576

Review 9.  New Approaches to Treat Osteoarthritis with Mesenchymal Stem Cells.

Authors:  Kiran Shah; Ashley G Zhao; Huseyin Sumer
Journal:  Stem Cells Int       Date:  2018-09-16       Impact factor: 5.443

10.  Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial.

Authors:  Jose Matas; Mario Orrego; Diego Amenabar; Catalina Infante; Rafael Tapia-Limonchi; Maria Ignacia Cadiz; Francisca Alcayaga-Miranda; Paz L González; Emilio Muse; Maroun Khoury; Fernando E Figueroa; Francisco Espinoza
Journal:  Stem Cells Transl Med       Date:  2018-12-28       Impact factor: 6.940
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.